These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28512229)

  • 1. Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Padmanabhan P; Dixit NM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4524-E4526. PubMed ID: 28512229
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
    Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.
    Xiao F; Fofana I; Thumann C; Mailly L; Alles R; Robinet E; Meyer N; Schaeffer M; Habersetzer F; Doffoël M; Leyssen P; Neyts J; Zeisel MB; Baumert TF
    Gut; 2015 Mar; 64(3):483-94. PubMed ID: 24848265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
    Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment.
    Uprichard SL; Sainz B
    Gut; 2015 Apr; 64(4):690-1. PubMed ID: 25287483
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral entry inhibition: too late for hepatitis C, but promising for other viral infections.
    Pawlotsky JM
    Gut; 2015 Mar; 64(3):362-4. PubMed ID: 25098973
    [No Abstract]   [Full Text] [Related]  

  • 7. Meet the Classes of Directly Acting Antiviral Agents: Strengths and Weaknesses.
    Chacko KR; Gaglio PJ
    Clin Liver Dis; 2015 Nov; 19(4):605-17, v. PubMed ID: 26466650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
    Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC
    PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gumming up the works: DNA polymers as HCV entry inhibitors.
    Counihan NA; Lindenbach BD
    Gastroenterology; 2009 Aug; 137(2):427-30. PubMed ID: 19563837
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus entry.
    Zeisel MB; Felmlee DJ; Baumert TF
    Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C viral entry inhibitors prolong viral suppression by replication inhibitors in persistently-infected Huh7 cultures.
    Bush CO; Greenstein AE; Delaney WE; Beran RK
    PLoS One; 2013; 8(6):e65273. PubMed ID: 23755208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'?
    Pécheur EI
    Gut; 2014 Jul; 63(7):1035-7. PubMed ID: 24092864
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds.
    Tai CJ; Li CL; Tai CJ; Wang CK; Lin LT
    J Vis Exp; 2015 Oct; (105):e53124. PubMed ID: 26555014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
    Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
    Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for synergy: Identifying optimal antiviral combination therapy using Hepatitis C virus (HCV) agents in a replicon system.
    Pomeroy JJ; Drusano GL; Rodriquez JL; Brown AN
    Antiviral Res; 2017 Oct; 146():149-152. PubMed ID: 28882564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
    Beard MR; Ffrench R; Gowans EJ; Helbig KJ; Eyre NM; Douglas MM; Grebely J; Ahlenstiel G; Locarnini S; George J; Shackel NA; White PA; Thompson AJ; Drummer HE
    Gastroenterology; 2014 Jul; 147(1):e1-4. PubMed ID: 24861641
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry.
    Bose M; Kamra M; Mullick R; Bhattacharya S; Das S; Karande AA
    Sci Rep; 2017 Jun; 7(1):3965. PubMed ID: 28638096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How hepatitis C virus invades hepatocytes: the mystery of viral entry.
    Zhu YZ; Qian XJ; Zhao P; Qi ZT
    World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.